WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

Oseltamivir and flu

Identifier

005585

Type of Spiritual Experience

Hallucination

Number of hallucinations: 1

Background

There may be amongst the ‘flu patients who have experienced hallucinations some who actually had flu and whose hallucinations were caused by very high temperatures, high temperature is normal with ‘flu and hyperthermia not uncommon. There is a separate section devoted to Hyperthermia. But hyperthermia does not account for all the figures, as is evident from the research

In this case I think we have the clue in the research – the cause was overdose and may have resulted in a toxic effect. But it appears that some research has shown the flu antivirals to be toxic to the liver in general, increasing chloresterol and also damaging various necessary functions of the liver….

 

Potential adverse effects of oseltamivir in rats: males are more vulnerable than females.   El-Sayed WM, Al-Kahtani MA - King Faisal University, Faculty of Science, Department of Biological Sciences, Al-Hufof 31982, Ahsaa, KSA.
Oseltamivir is the most widely used antiviral drug for the treatment and prophylaxis of influenza. However, not much is known about its adverse effects.
The potential side effects were investigated in male and female rats (140-170 g). Oseltamivir was administered at 2.2 mg·kg(-1)·day(-1) for 5 days. For both genders, treatment with oseltamivir resulted in significant reductions in the hepatic activities of glutathione reductase, glutathione peroxidase, and glutathione S-transferase. Also for both genders, oseltamivir produced modest reductions in the hepatic activities of UDP-glucuronosyltransferase, quinone oxidoreductase, thioredoxin reductase, CYP1A1/2, and CYP3A, as well as hepatic glutathione content. For both genders, neither the kidney functions nor protein profile was affected by oseltamivir. Oseltamivir also caused significant elevation in serum levels of both triacylglycerols and LDL-cholesterol and in the activity of γ-glutamyl transpeptidase, in both genders. For male animals only, oseltamivir treatment elevated the serum level of total cholesterol as well as the activity of serum alanine aminotransferase, and reduced the hepatic activities of superoxide dismutase and catalase.
Oseltamivir caused oxidative stress and acute toxicity in the liver, and disrupted the cholesterol and lipid metabolism but was less likely to cause serious drug interactions. There was a sexual differentiation in these adverse effects, with adverse effects being more evident in male rats.

 

A description of the experience

Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection - Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ.; School of Medicine, University of California, San Francisco, California, USA.

The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection.

The source of the experience

PubMed

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Antivirals
Influenza

Commonsteps

References